Analysts expect Bolt Biotherapeutics, Inc. to report revenue of 73,055.70 for Q3 26, against a range of 67,226.00 to 78,885.40. The most recent reported quarter, Q2 26, came in at 5,000.00, a 98.9% miss against the 465,727.50 consensus.
| Metric | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | Q3 26 | Q4 26 | Q1 27 | Q2 27 | Q3 27 | Q4 27 | Q1 28 | Q2 28 | Q3 28 | Q4 28 | Q1 29 | Q2 29 | Q3 29 | Q4 29 | Q1 30 | Q2 30 | Q3 30 | Q4 30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported (Actual) | 1.14 M | 10,000.00 | 1.22 M | 1.80 M | 2.17 M | 2.50 M | 26,000.00 | 5,000.00 | - | - | - | - | - | - | - | - | ||||||||||
| High Estimate | 1.33 M | 836,302.59 | 803,483.27 | 835,807.79 | 836,665.48 | 709,729.25 | 1.65 M | 501,385.46 | 78,885.40 | 59,751.54 | 0.00 | 0.00 | 380,616.84 | 431,261.41 | 1.71 M | 1.94 M | ||||||||||
| Low Estimate | 1.22 M | 785,700.95 | 747,455.61 | 725,594.63 | 738,720.58 | 664,090.95 | 1.49 M | 430,069.54 | 67,226.00 | 50,056.68 | 0.00 | 0.00 | 324,566.74 | 376,988.25 | 1.56 M | 1.62 M | ||||||||||
| Consensus Estimate | 1.28 M | 811,001.77 | 775,469.44 | 780,701.21 | 787,693.03 | 686,910.10 | 1.57 M | 465,727.50 | 73,055.70 | 54,904.11 | 0.00 | 0.00 | 352,591.79 | 404,124.83 | 1.63 M | 1.78 M |
Analysts expect Bolt Biotherapeutics, Inc. to report earnings per share of -3.73 for Q3 26, against a range of -3.88 to -3.58. The most recent reported quarter, Q2 26, came in at -4.57, a 26.2% miss against the -3.62 consensus.
| Metric | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | Q3 26 | Q4 26 | Q1 27 | Q2 27 | Q3 27 | Q4 27 | Q1 28 | Q2 28 | Q3 28 | Q4 28 | Q1 29 | Q2 29 | Q3 29 | Q4 29 | Q1 30 | Q2 30 | Q3 30 | Q4 30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported (Actual) | -8.00 | -8.40 | -5.80 | -4.46 | -3.72 | -3.84 | -4.31 | -4.57 | - | - | - | - | - | - | - | - | ||||||||||
| High Estimate | -5.90 | -6.67 | -6.96 | -5.84 | -4.90 | -5.51 | -2.78 | -3.46 | -3.58 | -3.61 | 0.00 | 0.00 | -1.71 | -2.76 | -6.37 | -6.43 | ||||||||||
| Low Estimate | -7.00 | -7.71 | -7.98 | -6.36 | -5.74 | -5.91 | -3.06 | -3.78 | -3.88 | -3.93 | 0.00 | 0.00 | -1.85 | -3.32 | -7.11 | -6.87 | ||||||||||
| Consensus Estimate | -6.45 | -7.19 | -7.47 | -6.10 | -5.32 | -5.71 | -2.92 | -3.62 | -3.73 | -3.77 | 0.00 | 0.00 | -1.78 | -3.04 | -6.74 | -6.65 |
Pull Wall Street consensus for Bolt Biotherapeutics, Inc. (high, low and consensus estimates alongside reported actuals) into your own models and apps with the Business Quant Estimates API. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/estimates?ticker=BOLT&mode=revenue&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/estimates"
params = {"ticker": "BOLT", "mode": "revenue", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/estimates?ticker=BOLT&mode=revenue&api_key=YOUR_API_KEY");
const data = await res.json();